Cooperative Agreement U01CA294539
Award Date
8/16/24
Completion Date
7/31/28
Dollars Obligated
$2.5M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Cancer Institute
Federal Grant Program
93.077
Assistance Type
Cooperative Agreement
Place of Performance
Baltimore, MD 21205, USA
Similar Awards
This Project Grant award of $622,957 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research by Duke University to investigate the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes. The study aims to analyze the flavors, sweeteners, and nicotine forms in these products, and...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA Program 93.077 - Family Smoking Prevention and Tobacco Control Act Regulatory Research provides $188,913 to Virginia Commonwealth University (VCU) from August 1, 2024 to July 31, 2029. The purpose of the grant is to assess perceptions of the continuum of risk among socioeconomically disadvantaged adult smokers, design and test educational messages about the relative risks of...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.310 (Trans-NIH Research Support) is supporting a $675,599 study titled "Implementation, Reach, and Impact of Court-Ordered Tobacco Corrective Statement Postings at the Point-of-Sale". The primary awardee is Rutgers, The State University of New Jersey, who will collaborate with Columbia University on the project. The study aims to: 1) characterize the implementation and reach of...
The National Institutes of Health (NIH) Office of the Director awarded a $1,197,896 Project Grant under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) to the University of Oklahoma Health Sciences Center. The objective of this 5-year longitudinal study is to use traditional survey methods combined with ecological momentary assessment (EMA) to better understand the impact of electronic nicotine delivery system (ENDS) product characteristics on...
This $2,353,743 Project Grant awarded by the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) will support research on the prevalence and effects of "natural" descriptors used in cigar packaging. The project aims to: 1) analyze Nielsen cigar sales data and purchased cigar packs to examine the use of "natural" themed descriptors and imagery on cigar packaging over time, 2) test the effects...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) totaling $885,824 aims to assess consumer response to smokeless tobacco modified risk marketing orders. The research activities will explore 1) consumers' exposure and reactions to authorized smokeless tobacco modified risk tobacco product (MRTP) claims, and 2) whether the MRTP claims influence smokeless tobacco demand and sensory evaluations. The project will be conducted...
This $3,230,000 Project Grant awarded by the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to investigate the cardiovascular effects of dual use of tobacco and nicotine delivery products, such as cigarettes and e-cigarettes. The project, awarded to the University of California, San Francisco (UCSF), aims to: (1) understand the cardiovascular health effects of...
This federal Project Grant award from the National Cancer Institute (CFDA 93.393 Cancer Cause and Prevention Research) will fund the development and evaluation of smoking health communications targeted to adults who smoke nondaily (ASN). The $164,484 award, effective August 11, 2025 through July 31, 2027, will support two main aims: Developing and iteratively refining smoking cessation messages for ASN that vary in affective valence (positive vs. negative) and type of consequences (social vs....
This Project Grant award of $515,632 from the National Cancer Institute's (NCI) Cancer Cause and Prevention Research program (CFDA 93.393) supports research to prepare the U.S. and state governments for the potential implementation of two cigarette product standards by the FDA - a menthol ban and a nicotine reduction standard. The key objectives are to: 1) Estimate for each U.S. state the increase in people who smoke that would quit and enroll in quit lines following the implementation of...
This Project Grant award from the National Institutes of Health's Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $549,555.45 to The Trustees of the University of Pennsylvania to investigate the exposure and respiratory health effects of chemical constituents from electronic cigarette (e-cigarette) use among young adults. The project aims to: 1) evaluate the relationship between e-cigarette use and exposure to metals and aldehydes, 2) assess...